Immune interaction between components of acellular pertussis-diphtheria- tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model

Vaccine

Volumn 24, Issue 17, 2006, Pages 3505-3512

  Mawas, Fatme ^a   Dickinson, Robert ^a   Douglas Bardsley, Alexandra ^a   Xing, Dorothy K L ^a   Sesardic, Dorothea ^a   Corbel, Michael J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Acelluar pertussis antigens; Combination vaccine; Diphtheria; Haemophilus influenzae b; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADHESINS, BACTERIAL; ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ALUMINUM HYDROXIDE; ANIMALS; B-LYMPHOCYTES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HAEMOPHILUS VACCINES; INTERFERON TYPE II; INTERLEUKIN-4; PHOSPHATES; POLYSACCHARIDES, BACTERIAL; RATS; RATS, SPRAGUE-DAWLEY; TETANUS TOXOID; VIRULENCE FACTORS, BORDETELLA;

EID: 33645226789     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.021     Document Type: Article

References (27)

1. E.K. Mulholland, A. Hoestermann, J.I. Ward, N. Maine, C. Ethevenaux, and B.M. Greenwood The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants Vaccine 14 9 1996 905 909
2. T. Cherian, N. Thomas, P. Raghupathy, I. Durot, and A. Dutta Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age Indian Pediatr. 39 5 2002 427 436
3. M.H. Slack, D. Schapira, and R.J. Thwaites Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines J Infect Dis 184 12 2001 1617 1620
4. J. Eskola, J. Ward, R. Dagan, D. Goldblatt, F. Zepp, and C.A. Siegrist Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis Lancet 354 9195 1999 2063 2068
5. M.E. Pichichero, and S. Passador Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine Clin Infect Dis 25 6 1997 1378 1384
6. S.A. Halperin, J. King, B. Law, E. Mills, and P. Willems Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses Clin Infect Dis 28 5 1999 995 1001
7. C.Y. Lee, J. Thipphawong, and L.M. Huang An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants Pediatrics 103 1 1999 25 30
8. E. Mills, R. Gold, and J. Thipphawong Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age Vaccine 16 6 1998 576 585
9. H.J. Schmitt, F. Zepp, and S. Muschenborn Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations Eur J Pediatr 157 3 1998 208 214
10. M.D. Decker Principles of pediatric combination vaccines and practical issues related to use in clinical practice Pediatr Infect Dis J 20 Suppl. 11 2001 S10 S18
11. M.E. Ramsay, J. McVernon, N.J. Andrews, P.T. Heath, and M.P. Slack Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method J Infect Dis 188 4 2003 481 485
12. P.T. Heath, R. Booy, and J. McVernon Hib vaccination in infants born prematurely Arch Dis Child 88 3 2003 206 210
13. G. Brenneman, D. Silimperi, and J. Ward Recurrent invasive Haemophilus influenzae type b disease in Alaskan Natives Pediatr Infect Dis J 6 4 1987 388 392
14. B.A. Claesson, B. Trollfors, and T. Lagergard Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children J Pediatr 112 5 1988 695 702
15. A.W. Sturgess, K. Rush, and R.J. Charbonneau Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide Vaccine 17 9-10 1999 1169 1178
16. M.P. Schutze, E. Deriaud, G. Przewlocki, and C. Leclerc Carrier-induced epitopic suppression is initiated through clonal dominance J Immunol 142 8 1989 2635 2640
17. F. Mawas, G. Newman, S. Burns, and M.J. Corbel Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model J Infect Dis 191 1 2005 58 64
18. R.M. Crisel, R.S. Baker, and D.E. Dorman Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan J Biol Chem 250 13 1975 4926 4930
19. R.A. Insel, P. Anderson, M.E. Pichichero, M.S. Amstey, G. Ekborg, and DH Smith S.H.W.P.F. Sell Epidemiology, immunology and prevention of disease 1982 Elsevier Press NY Anticapsular antibody to Haemophilus influenzae type b. p. 155
20. T. Barington, L. Hougs, and L. Juul The progeny of a single virgin B cell predominates the human recall B cell response to the capsular polysaccharide of Haemophilus influenzae type b J Immunol 157 9 1996 4016 4027
21. K. Redhead, D. Sesardic, and S.E. Yost Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests Vaccine 12 15 1994 1460 1466
22. R.K. Gupta, R. Anderson, and D. Cecchini Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and Haemophilus influenzae type b capsular polysaccharide conjugate vaccine Biologicals 27 2 1999 167 176
23. R. Dagan, J. Eskola, C. Leclerc, and O. Leroy Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants Infect Immun 66 5 1998 2093 2098
24. M.V. Lavigne, M. Castro, and N. Mateo Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen Microbes Infect 4 8 2002 815 820
25. J.E. Fischer, T.R. Johnson, R.S. Peebles, and B.S. Graham Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge J Infect Dis 180 3 1999 714 719
26. P. McGuirk, P.A. Johnson, E.J. Ryan, and K.H. Mills Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens J Infect Dis 182 4 2000 1286 1289
27. C. Canthaboo, L. Williams, D.K. Xing, and M.J. Corbel Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines Vaccine 19 6 2000 637 643